Sof’Bag®+

Sof’Bag®+
Product Description

Sof’Bag+ is an airless pouch-in-bottle packaging solution for prescription (Rx) and over-the-counter (OTC) formulations for dermal and transdermal application.

NEMERA

  • FR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

NEMERA

  • FR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

More Products from NEMERA (14)

  • DPI / PMDI

    Product DPI / PMDI

    From early-stage concept development to manufacturing we are truly a holistic partner in inhalation.
    With a long-standing know-how in inhalation delivery, we are today the leader in the Dry Powder Inhalers (DPIs) manufacturing business.
    Our expertise covers Dry Powder Inhalers (reservoir, blister ...
  • Pen Vario

    Product Pen Vario

    Our portfolio of disposable pens includes variable and fixed dose devices for automatic and manual drug administration, combining modern design with high intuitiveness of use for multidose therapies.
    PENVARIO – Dedicated to manufacturing of disposable, variable-dose pen injectors
  • Reusable pens

    Product Reusable pens

    Our reusable pens ensure the application of proven technological solutions with reliability, intuitiveness as well as ease-of-use.
  • Safe'n'Sound®

    Product Safe'n'Sound®

    Safe’n’Sound® (1ml & 2.25ml) is a highly customizable platform of add-on passive safety devices for prefilled syringes. It helps in preventing needlestick injuries, providing user-friendly protection for healthcare professionals and patients or caregivers.
    Ergonomically designed, Safe’n’Sound® is i...
  • Safe'n'Spray®

    Product Safe'n'Spray®

    Safe’n’Spray®, the new smart nasal spray with locking features, dramatically improves the existing way of administrating specific pain treatments, avoiding the risk of overdosing.
  • Sof’Airless XS+

    Product Sof’Airless XS+

    Sof’Airless XS+ is a protective mini-airless system for small dose applications and sampling.
    It is the solution for trial sizes or local treatments with very little skin surface to cover.
    It targets Rx and OTC dermal gels and creams and is already used for cold sore treatments.
  • Unispray

    Product Unispray

    Unispray is a ready-to-use primeless nasal device with accurate single-metered liquid dose delivery. It offers one-handed activation with 360° functionality to face emergency and crisis.
    Thanks to its ergonomic design, it is intuitive and easy-to-use.
  • Oral, Vaginal, Rectal

    Product Oral, Vaginal, Rectal

    We offer millimeter solutions in medicine applicators and dispensers, being today a global reference for quality and precision in this segment.
    Our systems aim to be used for oral, vaginal and rectal treatments such as Oral infections, Vaginal infections, and Rectal diseases.
  • Sof'Airless: mini airless system for small dose dermal applications

    Product Sof'Airless: mini airless system for small dose dermal applications

    Nemera offers high performance airless delivery systems for dermal and transdermal solutions, lotions and creams.

    Nemera’s airless systems, pumps and valves are designed to handle a variety of formulations with different viscosities.



    Sof’Airless XS is a protective ...
  • PUMPS SP27 / SP270+: quality and performance for ENT sprays

    Product PUMPS SP27 / SP270+: quality and performance for ENT sprays

    Nemera offers an extensive range of metered pumps and valves, compatible with a wide choice of actuators in different shapes and fitments for nasal, buccal and auricular delivery.
    Here our different pumps:
    SP27 - SP 37: Quality systems for unregulated markets

    SP270+ - SP370+: Qual...
  • Safe’n’Sound®: our passive safety device – Robust and ergonomic design for user safety

    Product Safe’n’Sound®: our passive safety device – Robust and ergonomic design for user safety

    Safe’n’Sound®: the safety device solution for small molecules and biologics
    Nemera leverages decades of manufacturing and development experience in parenteral complex devices moulding and assembly such as safety devices, pens, autoinjectors and implanters.

    Nemera’s Safe’n’Sou...
  • Novelia®: Nemera’s preservative-free multidose eyedropper

    Product Novelia®: Nemera’s preservative-free multidose eyedropper

    Novelia®: Nemera’s preservative-free multidose eyedropper, is used across 4 continents
    Preservatives have been shown to be harmful to the eye and can lead patients to discontinue or skip treatment to avoid irritation and discomfort.
    The new preservative-free multidose ophthalmic packaging Nove...

NEMERA resources (9)

  • News Nemera: Stronger than ever

    More modern, our new brand identity truly embodies who we are, how we partner with our customers and ultimately the value we bring to millions of patients across the world through our drug delivery device solutions.
  • Video Innovation in Connectivity Roundtable pt.1

    The Innovation in Connectivity Roundtable originally aired as part of Pharmapack Europe 2021 Part 1 of this session includes three presentations: Patient Journey Driven Considerations for Integrating Digital Health for Combination Products The importance of utilizing applied ethnography and other primary research methods to understand the patient journey as the foundation for integrating digital health into a device/combination product development initiative. Considering patient needs in the context of a larger ecosystem including providers, payers, and regulators to develop a robust plan with respect to connectivity and digital health. Examples of how this understanding is applied across the combination product development journey through organic development, utilization of platform devices, or as a lifecycle management enchantments while optimizing the user experience resulting in safe, effective, and differentiated combination products. Mark Tunkel, Global Category Director for Insight Innovation, Nemera Electronic Product Information: A Case Study on Medicine Labelling for the Visually Impaired The Electronic Product Information Initiative for Medicines (ePI) aim to ease the accessibility of product information to everyone, including visually impaired patients. The GS1 Digital Link aim to provide a single barcode for identification, brand protection, and access to product information for patients. Our lecture will illustrate how the existing Datamatrix on packaging could be leveraged, today, by everyone, including visually impaired users, to access a tailored and relevant information. Laurent Tonnelier, CEO, mobiLead - xTag Lise Wagner, Accessibility Specialist and User Expert, OKEENEA Traceability of Medicines: from Finished Product to Unit Dose Delivery Challenges for B2B Supply Chain stakeholders Regulations: a global overview What about B2C Nathalie Wardé, CEO & Founder, D4P pharma Join the above speakers and moderator Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG for the live panel discussion that followed in the Innovation in Connectivity Roundtable pt. 2
  • News Pharmapack Europe 2021 announces Awards winners!

    Awards showcased a wide range of industry-changing innovations in packaging and drug delivery, with sustainability emerging as a key metric across all categories
  • Video Innovation in Connectivity Roundtable pt. 2

    The second part of the Innovation in Connectivity Roundtable brings together presenters from Nemera, D4P Pharma and xTag for a group discussion and live Q&A (45-minutes). Moderated by Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG Participants: Mark Tunkel, Global Category Director for Insight Innovation, Nemera Laurent Tonnelier, CEO, mobiLead – xTag Lise Wagner, Accessibility Specialist and User Expert, OKEENEA Nathalie Wardé, CEO & Founder, D4P pharma This webinar originally aired as part of Pharmapack 2021
  • News Pharmapack 2021: Increasing connectivity is the key to patient centricity and simplified access to product information

    During the live Innovation in Connectivity Roundtable at the Pharmapack 2021 online conference, experts discussed how the latest innovations in digital technology are shaping industry ambitions to put the patient journey at the heart of its drug device and delivery solutions by simplifying product information via increased connectivity.
  • Video Welcome to the Digital Health & Connectivity & Patient-Centricity Track

    This webinar will address: Key market trends in digital health and how they have accelerated in the past years Nemera’s vision of digital health and the implications on the whole drug/device development ecosystem – how connectivity is creating incredible opportunities for the industry but also raises some challenges: link to conferences in the track How does Nemera play in this landscape: presentation of the company, our capabilities and some examples of our connected devices. Webinar originally aired as part of Pharmapack Europe 2021
  • News RETRONOSE: IMPROVING NASAL DELIVERY THROUGH NEW AND IMPROVED DEVICE

    RetroNose is a completely new drug delivery concept to dispense drug formulation to the nasal cavity. The principle of this concept is to deliver a spray through the oral cavity to deposit the drug in the nasal cavity from rear to front. To avoid aerosol penetration in the lung and to ensure deposition efficacy, the aerosol drug is automatically delivered during the nasal expiratory phase.
  • Video Nemera: We Put Patients First

    As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint to market of their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission.
    For more information, visit www.nemera.net
  • Video NEMERA CEO SHARES 2021 AMBITION

    Our CEO, Marc Hämel shares the lessons we learned from last year, extends his wishes, gratitude to the Nemera family and walks us through the top company goals that will shape and drive our story in 2021!